← Back to federal legislation
S. 2121In committee

SUPPORT for Patients and Communities Reauthorization Act of 2025

Introduced: Jun 18, 2025

Latest action date: Jun 18, 2025

Latest development

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Congress
119th Congress
Introduced
Jun 18, 2025
Recorded roll calls
0

Status detail: The most advanced recorded stage is committee consideration.

Plain-language overview

What this bill does

SUPPORT for Patients and Communities Reauthorization Act of 2025

This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.

For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to

•    addressing substance use disorders with respect to pregnant and postpartum women,
•    prevention and recovery from substance use disorders for youth, 
•    housing for individuals in recovery from substance use disorders,
•    community organizations facilitating recovery from substance use disorders,
•    loan repayment for certain health care providers treating substance use disorders, 
•    prevention of overdoses of controlled substances,
•    treatment of children experiencing psychological trauma, and
•    mental and behavioral health education and training for medical and allied health students.

Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

Additionally, the bill establishes new requirements for HHS, including requirements relating to

•    protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
•    establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
•    reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Official summary from Congress.gov.

Civixly topics

What this legislation is about

Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.

Official CRS policy area

Health

Committee activity

Committees and subcommittees that received, reviewed, marked up, or reported this legislation.

Amendments

Proposed changes to this measure, with their latest official outcome or action from Congress.gov.

No amendments are listed for this measure.

Checked against Congress.gov Oct 24, 2026.

Action timeline

Newest action first. Action language comes from the official Congress.gov record.

View full action timeline2 actions
  1. Introduced in Senate

    IntroReferralLibrary of Congress
  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    IntroReferralSenate

Roll-call votes

Recorded House and Senate votes connected to this bill. Your representatives appear first when available.

No connected roll-call votes are currently available for this bill.

Discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

Sources: Congress.gov and official House and Senate vote records.

View data freshness details

Base metadata check pending · Civixly summary check pending · Action timeline checked Oct 24, 2026 · Sponsorship checked Oct 11, 2026 · Topics checked Oct 24, 2026 · Committees checked Oct 24, 2026 · Status checked Oct 24, 2026 · Related bills checked Oct 24, 2026.